Table 2.
Multivariate logistic regression analysis for predictors of in‐hospital outcome
| Variable | OR | 95% CI | p‐Value |
|---|---|---|---|
| Hypertension | 1.095 | 0.800–1.497 | .571 |
| Diabetes | 1.342 | 0.912–1.974 | .136 |
| Previous stroke | 2.722 | 1.808–4.098 | <.001 |
| LVEF (%) | 0.943 | 0.926–0.960 | <.001 |
| Grace score | 1.042 | 1.035–1.049 | <.001 |
| hs‐CRP (mg/L) | 1.100 | 1.076–1.124 | <.001 |
| WBC count (×109/L) | 1.067 | 1.011–1.125 | .017 |
| Hemoglobin (g/L) | 1.001 | 0.991–1.010 | .91 |
| Uric acid (umol/L) | 1.001 | 1.000–1.003 | .188 |
| FBG (mmol/L) | 0.989 | 0.933–1.048 | .713 |
| HbA1c (%) | 1.063 | 0.934–1.209 | .358 |
| TG (mmol/L) | 0.997 | 0.891–1.116 | .962 |
| LM disease | 1.283 | 0.758–2.172 | .353 |
| Three‐vessel disease | 1.013 | 0.751–1.366 | .933 |
| LAD | 1.391 | 1.025–1.889 | .034 |
| LCX | 1.077 | 0.753–1.540 | .685 |
| STEMI | 2.208 | 1.603–3.041 | <.001 |
| ACEI/ARB | 1.545 | 1.143–2.088 | .005 |
| β‐Blockers | 1.132 | 0.777–1.649 | .519 |
| IIbIIIA | 1.430 | 0.966–2.116 | .074 |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; CI, confidence interval; FBG, fasting blood glucose; Grace, Global Registry of Acute Coronary Events; HbA1c, glycosylated hemoglobin A1c; hs‐CRP high‐sensitivity C‐reactive protein; IIbIIIA, IIBbIIIA receptor antagonist; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main; LVEF, left ventricular ejection fraction; OR, odds ratio; STEMI, ST‐segment elevation myocardial infarction; TC, total cholesterol; TG, triglycerides; WBC, white blood cell.